Phase 1 Study for Safety and Tolerability of HL036

NCT02717208 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

20

Enrollment

INDUSTRY

Sponsor class

Conditions

Dry Eye

Interventions

BIOLOGICAL: HL036
BIOLOGICAL: Vehicle

Sponsor

HanAll BioPharma Co., Ltd.